Gimv and Edmond de Rothschild Investment Partners (EdRip) have sold Swiss biotech Covagen to Cilag International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Investindustrial sells its remaining stake of 4.12% in the company, fully exiting the investment
Following the deal, CCV Schweiz will be integrated with Concardis Schweiz, which is part of Nets Group
Minority shareholder IMS Capital has also filed for insolvency; Getnow is now seeking new investors
Exit from Rutland Fund III realises a return of 5.7x on the original cost of the investment